Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Superior outcome from frontline cord blood transfusion combined HLA-full-matched unrelated donor hematopoietic stem cell transplantation for aplastic anemia

View Full Paper
Ask AI
Bookmark
Share

Authors

THTonglin HuRZRui ZhengQYQinghong Yu

Discussion

Loading...

Member takes

Overview

Retrospective analysis found superior survival rates with cord blood and matched unrelated donor transplant in aplastic anemia patients, suggesting potential benefits over traditional methods.

Key Points

  • Hematopoietic stem cell transplantation improved overall survival in aplastic anemia patients in this analysis.
  • The study showed a notable lower incidence of graft-versus-host disease among patients treated with cord blood transplants.
  • Hematopoietic stem cell transplantation methods compared include matched sibling donor and haploidentical donor approaches.
  • Further clinical investigations are needed to validate the promising outcomes of fully HLA-matched cord blood transplants.

Cite This Study

Hu et al. (2025) studied this question.

synapsesocial.com/papers/69362f7f4fa91c937236e533https://doi.org/10.1182/blood-2025-2512
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Matched unrelated vs. Haploidentical  donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis – a randomized prospective european trial.2025 · 2 citations
  2. 2T cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT2025
  3. 3No reduction in gvhd risk for aplastic anemia patients to combined third-party unrelated cord blood in haploidentical hematopoietic stem cells transplantation2025
  4. 4Haploidentical transplantation combined with mesenchymal stem cells co-infusion improves survival in severe aplastic anemia: a single-center retrospective study2025
  5. 5Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.2025 · 1 citations